LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 240

Search options

  1. Book: Chemotherapy for gynecological neoplasms

    Angioli, Roberto

    (Basic and clinical oncology ; 28)

    2004  

    Author's details ed. by Roberto Angioli
    Series title Basic and clinical oncology ; 28
    Collection
    Keywords Genital Neoplasms, Female / drug therapy ; Drug Therapy / methods
    Language English
    Size XVII, 685 S. : Ill., graph. Darst.
    Publisher Dekker
    Publishing place New York u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT013930331
    ISBN 0-8247-5418-2 ; 978-0-8247-5418-1
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Multimodality therapy in gynecologic oncology

    Angioli, Roberto / Sevin, Bernd-Uwe

    64 tables

    1996  

    Author's details ed. by Bernd-Uwe Sevin ... With contributions by R. Angioli
    Keywords Genital Neoplasms, Female / therapy ; Combined Modality Therapy ; Breast Neoplasms / therapy ; Gynäkologische Onkologie
    Language English
    Size X, 238 S. : Ill., graph. Darst.
    Publisher Thieme
    Publishing place Stuttgart u.a.
    Document type Book
    HBZ-ID HT007259627
    ISBN 3-13-101241-2 ; 0-86577-588-5 ; 978-3-13-101241-8 ; 978-0-86577-588-6
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  3. Article ; Online: The role of sentinel node in gynecologic malignancies.

    Plotti, Francesco / Angioli, Roberto

    Minerva ginecologica

    2020  Volume 72, Issue 6, Page(s) 359–360

    MeSH term(s) Female ; Genital Neoplasms, Female/pathology ; Humans ; Lymph Node Excision ; Neoplasm Staging ; Sentinel Lymph Node/pathology ; Sentinel Lymph Node Biopsy
    Language English
    Publishing date 2020-09-03
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 80159-8
    ISSN 1827-1650 ; 0026-4784 ; 0325-8793
    ISSN (online) 1827-1650
    ISSN 0026-4784 ; 0325-8793
    DOI 10.23736/S0026-4784.20.04637-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study.

    Angioli, Roberto / Santonico, Marco / Pennazza, Giorgio / Montera, Roberto / Luvero, Daniela / Gatti, Alessandra / Zompanti, Alessandro / Finamore, Panaiotis / Incalzi, Raffaele Antonelli

    Diagnostics (Basel, Switzerland)

    2024  Volume 14, Issue 5

    Abstract: Ovarian cancer (OC) is the eighth most common cancer in women. Since screening programs do not exist, it is often diagnosed in advanced stages. Today, the detection of OC is based on clinical examination, transvaginal ultrasound (US), and serum biomarker ...

    Abstract Ovarian cancer (OC) is the eighth most common cancer in women. Since screening programs do not exist, it is often diagnosed in advanced stages. Today, the detection of OC is based on clinical examination, transvaginal ultrasound (US), and serum biomarker (Carbohydrate Antigen 125 (CA 125) and Human Epididymis Protein 4 (HE4)) dosage, with a sensitivity of 88% and 95%, respectively, and a specificity of 84% for US and 76% for biomarkers. These methods are clearly not enough, and OC in its early stages is often missed. Many scientists have recently focused their attention on volatile organic compounds (VOCs). These are gaseous molecules, found in the breath, that could provide interesting information on several diseases, including solid tumors. To detect VOCs, an electronic nose was invented by a group of researchers. A similar device, the e-tongue, was later created to detect specific molecules in liquids. For the first time in the literature, we investigated the potential use of the electronic nose and the electronic tongue to detect ovarian cancer not just from breath but also from urine, blood, and plasma samples.
    Language English
    Publishing date 2024-03-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662336-5
    ISSN 2075-4418
    ISSN 2075-4418
    DOI 10.3390/diagnostics14050561
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The efficacy and feasibility of fractional CO2 laser therapy for the treatment of urinary incontinence: a multicentric case-control study.

    Luvero, Daniela / Angioli, Roberto / Baruch, Yoav / Salvatore, Stefano / Filippini, Maurizio / Pieralli, Annalisa / Montera, Roberto

    Minerva obstetrics and gynecology

    2023  

    Abstract: Background: Female urinary incontinence is a significant public health problem. Conservative treatments require high patient compliance, while surgery often leads to more complications and recovery time. Our aim is to evaluate the efficacy of ... ...

    Abstract Background: Female urinary incontinence is a significant public health problem. Conservative treatments require high patient compliance, while surgery often leads to more complications and recovery time. Our aim is to evaluate the efficacy of microablative fractional CO<inf>2</inf> laser (CO<inf>2</inf>-laser) therapy in women with urinary incontinence (UI).
    Methods: This is a retrospective analysis of prospectively collected data on women with stress urinary incontinence (SUI) and mixed urinary incontinence (MUI) with predominant SUI subjected to four sessions of CO<inf>2</inf>-laser therapy performed once a month, between February 2017 and October 2017, with a 12-month follow-up. The subjective Visual Analogue Scale (VAS) 0-10 was used to score and variables were evaluated at baseline and at one, six and 12 months after initiation of therapy. Finally, results were compared to a control group.
    Results: The cohort consisted of 42 women. The proportion of patients with vaginal atrophy among those younger than 55 years was substantially lower (3/23; 13%) than among those older than 55 years (15/19; 78.9%). CO<inf>2</inf> laser treatment was associated with a significant improvement in VAS scores recorded one-month, six-months, and one-year, after conclusion of therapy (P<0.001). VAS scores improved significantly in patients with either SUI (26/42; 61.9%) or mixed UI (16/42; 38.1%). No major post treatment complications were registered. Women with vaginal atrophy demonstrated significantly better results (P<0.001).
    Conclusions: Results confirm the efficacy and a good safety profile, for CO<inf>2</inf> laser treatment in SUI, mostly in women with postmenopausal vaginal atrophy and should be considered as a treatment option for female patients with concomitant SUI and vaginal atrophy.
    Language English
    Publishing date 2023-05-04
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 3062815-5
    ISSN 2724-6450
    ISSN (online) 2724-6450
    DOI 10.23736/S2724-606X.23.05290-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The use of sealing hemostat patch (HEMOPATCH

    Montera, Roberto / Ficarola, Fernando / Plotti, Francesco / Terranova, Corrado / De Cicco Nardone, Carlo / Guzzo, Federica / Angioli, Roberto / Luvero, Daniela

    Archives of gynecology and obstetrics

    2023  Volume 307, Issue 5, Page(s) 1521–1528

    Abstract: Purpose: Uterine myomas are the most common gynecological disease. In these cases, a myomectomy is performed traditionally laparotomically. However, alternatives have been widely used, including laparoscopic, endoscopic, and robotic surgery. During ... ...

    Abstract Purpose: Uterine myomas are the most common gynecological disease. In these cases, a myomectomy is performed traditionally laparotomically. However, alternatives have been widely used, including laparoscopic, endoscopic, and robotic surgery. During these techniques, diffuse parenchymatous bleeding remains one of the main intraoperative and postoperative complications and sometimes requires unplanned hysterectomies. Recently, hemostatic agents and sealants have been used to prevent excessive blood loss during surgical repair.
    Methods: We propose a prospective case-control study on the use of a sealing hemostat patch (HEMOPATCH
    Results: In group A, we achieve faster hemostasis (p < 0.05), than in group B. We report a significantly lower C-reactive protein value on the second and third days after surgery for group A compared to group B.
    Conclusions: HEMOPATCH
    MeSH term(s) Female ; Humans ; Uterine Myomectomy/methods ; Blood Loss, Surgical/prevention & control ; Case-Control Studies ; Leiomyoma/surgery ; Leiomyoma/etiology ; Hemostatics/therapeutic use ; Laparoscopy/methods ; Uterine Neoplasms/surgery ; Uterine Neoplasms/etiology
    Chemical Substances Hemostatics
    Language English
    Publishing date 2023-02-15
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 896455-5
    ISSN 1432-0711 ; 0932-0067
    ISSN (online) 1432-0711
    ISSN 0932-0067
    DOI 10.1007/s00404-023-06957-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Intraoperative Three-Dimensional Transvaginal Ultrasound for Hysteroscopic Metroplasty: a Controlled Study.

    Muzii, Ludovico / Galati, Giulia / Mattei, Giulia / Romito, Alessia / Di Donato, Violante / Palaia, Innocenza / Bogani, Giorgio / Angioli, Roberto

    Reproductive sciences (Thousand Oaks, Calif.)

    2023  Volume 30, Issue 11, Page(s) 3372–3378

    Abstract: This study aims to evaluate the role of intraoperative transvaginal three-dimensional ultrasound (3DUS) during hysteroscopic metroplasty. This is a prospective cohort of consecutive patients with septate uterus undergoing hysteroscopic metroplasty with ... ...

    Abstract This study aims to evaluate the role of intraoperative transvaginal three-dimensional ultrasound (3DUS) during hysteroscopic metroplasty. This is a prospective cohort of consecutive patients with septate uterus undergoing hysteroscopic metroplasty with intraoperative transvaginal 3DUS guidance compared to a historical control group of patients undergoing hysteroscopic metroplasty without 3DUS. We conducted our research in a tertiary care university hospital in Rome, Italy. This study involved nineteen patients undergoing 3DUS-guided hysteroscopic metroplasty for recurrent abortion or infertility compared to 19 age-matched controls undergoing metroplasty without 3DUS guidance. During hysteroscopic metroplasty, 3DUS was performed in the study group when the operator considered the procedure to be completed, according to standards of operative hysteroscopy. If 3DUS diagnosed a residual septum, the procedure was continued until a 3DUS diagnosis of a normal fundus was obtained. The patients were followed with a 3DUS performed 3 months after the procedure. The numbers of complete resections (residual septum absent), suboptimal resections (measurable residual septum of less than 10 mm), and incomplete resections (residual septum > 10 mm) in the intraoperative 3DUS group were compared to the numbers in the control group with no intraoperative 3DUS. At follow-up, measurable residual septa were obtained in 0% of the patients in the 3DUS-guided group versus 26% in the control group (p = 0.04). Residual septa of > 10 mm were obtained in 0% of the 3DUS group versus 10.5% in the control group (p = 0.48). Intraoperative 3DUS reduces the incidence of suboptimal septal resections at hysteroscopic metroplasty.
    MeSH term(s) Pregnancy ; Female ; Humans ; Prospective Studies ; Uterus/diagnostic imaging ; Uterus/surgery ; Hysteroscopy/methods ; Ultrasonography ; Infertility, Female/diagnostic imaging ; Infertility, Female/surgery ; Infertility, Female/etiology
    Language English
    Publishing date 2023-06-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2276411-2
    ISSN 1933-7205 ; 1933-7191
    ISSN (online) 1933-7205
    ISSN 1933-7191
    DOI 10.1007/s43032-023-01277-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial.

    Terranova, Corrado / Schiavoni, Lorenzo / Ficarola, Fernando / Plotti, Francesco / De Cicco Nardone, Carlo / Montera, Roberto / Lotierzo, Michela / Bartolone, Martina / Pascarella, Giuseppe / Mattei, Alessia / Costa, Fabio / Agrò, Felice Eugenio / Angioli, Roberto

    Gynecologic and obstetric investigation

    2024  Volume 89, Issue 2, Page(s) 103–110

    Abstract: Objectives: The aim of the study was to compare, in patients undergoing minor gynecological laparoscopic procedures, the effects of ultrasound (US)-guided transversus abdominis plane (TAP) + rectus sheath (RS) block versus no TAP/RS block in terms of ... ...

    Abstract Objectives: The aim of the study was to compare, in patients undergoing minor gynecological laparoscopic procedures, the effects of ultrasound (US)-guided transversus abdominis plane (TAP) + rectus sheath (RS) block versus no TAP/RS block in terms of post-surgical pain control using the numeric pain rating scale (NRS) and the degree of patient satisfaction, according to the main goals of Early Recovery After Surgery (ERAS) programs. The primary outcome is to value the postoperative abdominal pain using NRS in both groups. Secondary outcomes are to evaluate blood values, presence of postoperative nausea and vomiting (PONV), postoperative ileus, level of patient expected satisfaction, time of discharge, length of stay (LOS), and the amounts of additional analgesics required.
    Design: In this prospective randomized controlled trial, patients were randomly assigned to loco-regional anesthesia (LRA) group, who received TAP and RS block under US guidance, or no loco-regional anesthesia (N-LRA) group. Enrolled patients were randomized 1:1 to either receive bilateral TAP/RS block with ropivacaine or sham treatment (patches were applied on the abdominal wall of the patients under general anesthesia).
    Participants: All patients aged between 18 and 75 years, with ASA (American Society of Anesthesiologists) physical status 1-2, undergoing laparoscopic minor gynecological surgery, were enrolled.
    Setting: The study was conducted to the University of Campus Bio-Medico Hospital of Rome.
    Methods: Half an hour before surgery, all patients received gabapentin 300 mg per os. Once the patient underwent general anesthesia, US-guided bilateral TAP/RS block was performed by the anesthesiology team, while the uterine manipulator was positioned by a gynecology resident (not involved in the study). In the operative room, all patients received the same standardized anesthetic regimen. Postoperative abdominal pain was assessed at rest, after palpation, during movement, and after a cough by evaluating the patient at 6, 12, 18, 24, 36, 48, and 72 h after surgery, using the NRS from 0 to 10 in both groups. The amount of drug used for analgesia in the first 48 h after surgery was recorded. Moreover, hemoglobin, white blood cells, and c-reactive protein levels were recorded at 24, 48, and 72 h. The presence of PONV and the postoperative ileus was recorded throughout convalescence. The expected level of patient satisfaction at discharge and finally the LOS were assessed.
    Limitations: The major weakness of this study is that 60 mL of 0.5% ropivacaine was administered to each patient, without considering weight differences, yet contemporary literature rarely suggests volume/dose titration in fascial blocks.
    Results: A total of 104 women, undergoing gynecological minor laparoscopic surgery, were enrolled and assigned to LRA group (53 pts) and N-LRA group (51 pts). Postoperative pain was significantly reduced in patients who received TAP/RS block. A reduction in the intake of non-steroidal anti-inflammatory drugs after surgery was registered in LRA group (p < 0.01). Moreover, a significant reduction of LOS (45.97 ± 9.87 vs. 65.08 ± 17.32 h; p < 0.01) and PONV was observed in the LRA group, as well as a better level of patient satisfaction at discharge (9.43 ± 0.94 vs. 8.26 ± 1.19; p < 0.01), compared to the N-LRA group.
    Conclusions: US-guided TAP and RS block significantly reduces postoperative pain after minor gynecologic laparoscopic surgery and improves patients' post-operative recovery.
    MeSH term(s) Humans ; Female ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Ropivacaine/therapeutic use ; Abdominal Wall ; Postoperative Nausea and Vomiting/epidemiology ; Prospective Studies ; Abdominal Muscles ; Pain, Postoperative/drug therapy ; Laparoscopy ; Gynecologic Surgical Procedures ; Ileus ; Abdominal Pain ; Anesthetics, Local/therapeutic use
    Chemical Substances Ropivacaine (7IO5LYA57N) ; Anesthetics, Local
    Language English
    Publishing date 2024-01-24
    Publishing country Switzerland
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 800003-7
    ISSN 1423-002X ; 0378-7346
    ISSN (online) 1423-002X
    ISSN 0378-7346
    DOI 10.1159/000535835
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?

    Luvero, Daniela / Lopez, Salvatore / Bogani, Giorgio / Raspagliesi, Francesco / Angioli, Roberto

    Vaccines

    2020  Volume 8, Issue 4

    Abstract: Cervical cancer (CC) is the second leading cause of cancer death in women aged 20-39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three ... ...

    Abstract Cervical cancer (CC) is the second leading cause of cancer death in women aged 20-39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three HPVs vaccines are currently on the global market: bivalent, quadrivalent, and nonavalent. The nonavalent vaccine provides protection against almost 90% of HPV-related CC. Despite availability of primary and secondary prevention measures, CC persists as one of the most common cancers among women around the world. Although CC is a largely preventable disease, management of persistent or recurrent CC no longer amenable to control with surgery or radiation therapy has not improved significantly with the progress of modern chemotherapy and disseminated carcinoma of the cervix remains a discouraging clinical entity with a 1-year survival rate between 10% and 15%. Over the last few years, there has been increasing interest in immunotherapy as a strategy to fight tumors. This article focuses on recent discoveries about the HPV vaccine and immunotherapies in the prevention and treatment of CC, highlighting the future view.
    Language English
    Publishing date 2020-10-10
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines8040597
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Two viral infections in Japan.

    Fujiwara, Keiichi / Quinn, Michael A / Coleman, Robert L / Angioli, Roberto

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

    2020  Volume 30, Issue 8, Page(s) 1258–1259

    MeSH term(s) Anti-Vaccination Movement ; COVID-19/prevention & control ; Female ; Health Policy ; Humans ; Japan/epidemiology ; Papillomavirus Infections/prevention & control ; SARS-CoV-2 ; Uterine Cervical Neoplasms/mortality ; Uterine Cervical Neoplasms/prevention & control ; Vaccination Coverage
    Keywords covid19
    Language English
    Publishing date 2020-07-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 1070385-8
    ISSN 1525-1438 ; 1048-891X
    ISSN (online) 1525-1438
    ISSN 1048-891X
    DOI 10.1136/ijgc-2020-001735
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top